Company Overview - Vicarious Surgical is a pioneering surgical robotics company focused on revolutionizing surgery through human-like robots that facilitate minimally invasive procedures, enhancing surgical efficiency, improving patient outcomes, and reducing healthcare costs [2][4] Partnership Details - Vicarious Surgical has entered a strategic development agreement with LSU Health New Orleans, which provides access to a vast network and expertise, aimed at refining training protocols and fostering surgeon adoption of its V1.0 surgical robot [1][3] - The partnership is expected to accelerate the validation and adoption of Vicarious Surgical's robotic platform, ultimately improving surgical outcomes and reducing healthcare costs [3] Product Development - The Vicarious Surgical robotic platform, Version 1.0 (V1.0), is designed to enhance surgical efficiency and patient outcomes while reducing healthcare costs through minimally invasive procedures [4] - The company plans to submit V1.0 for FDA approval by early to mid-2026, with cadaveric testing scheduled for spring and final refinements planned for fall [4] Industry Prospects - The surgical robots market was valued at $7.1 billion in 2023 and is projected to reach $26.4 billion by 2032, growing at a CAGR of 16.1%, driven by increased adoption of surgical robots, rising surgical procedures, and growing healthcare expenditures [5] Price Performance - Vicarious Surgical's shares (RBOT) have decreased by 45.6% this year, contrasting with a 3.6% rise in the industry and a 10% increase in the S&P 500 during the same period [6]

Vicarious Surgical (NYSE:RBOT) just reported results for the first quarter of 2024.Vicarious Surgical reported earnings per share of -9 cents. This met the analyst estimate for EPS of -9 cents.The company did not report any revenue for the quarter.InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estima ...

Vicarious Surgical Inc. (NYSE:RBOT) Q1 2024 Earnings Conference Call April 29, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - Head, Investor Relations Adam Sachs - Co-Founder and CEO Bill Kelly - Chief Financial Officer Randy Clark - President Conference Call Participants Ryan Zimmerman - BTIG Adam Maeder - Piper Sandler Josh Jennings - TD Cowen Operator Hello. And welcome to Vicarious Surgical’s 2024 First Quarter Earnings Call. My name is Elliot, and I’ll be coordinating your call today. [Operator ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39384 VICARIOUS SURGICAL INC. (Exact name of registrant as specified in its charter) | --- | --- | |--------------------------- ...

Exhibit 99.1 Vicarious Surgical Reports First Quarter 2024 Financial Results WALTHAM, Mass.-- (BUSINESS WIRE) – April 29, 2024 – Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives through the transformation of surgical robotics, today announced financial results for the quarter ended March 31, 2024. Management will host a corresponding conference call at 4:30 p.m. ET today, April 29, 2024. "I'm proud t ...

Vicarious Surgical Inc. (NYSE:RBOT) Q4 2023 Earnings Conference Call March 4, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - IR Adam Sachs - CEO William Kelly - CFO Conference Call Participants Ryan Zimmerman - BTIG Operator Good afternoon, and welcome to Vicarious Surgical's Fourth Quarter 2023 Earnings Conference Call. My name is Matt, and I'll be your operator for today's call. At this time, all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards t ...

Exhibit 99.1 Vicarious Surgical Reports Fourth Quarter and Full Year 2023 Financial Results Version 1.0 Surgical System On Track for Cadaveric Testing in the Spring Achieves Full Year 2023 Cash Burn Objective of $63.4 Million Narrows Full Year 2024 Cash Burn Guidance to Approximately $50 Million WALTHAM, Mass.-- (BUSINESS WIRE) – March 4, 2024 – Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outc ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM __________ TO ________ COMMISSION FILE NUMBER 001-39384 VICARIOUS SURGICAL INC. (Exact name of registrant as specified in its charter) | --- | --- | |------------------------ ...

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the Company will participate in the TD Cowen 44th Annual Healthcare Conference. Management is scheduled to present on Tuesday, March 5, 2024 at 2:10 p.m. ET. A live webcast of the presentation will be accessible to the public on ...

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the fourth quarter and full year ended December 31, 2023 after the market closes on Monday, March 4, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested ...